×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Incathlab member and receive full access to its content!
You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.
Registration Login
Registration Login
Protocole:
- OptiRAY® (ioversol)
- Concentration: 350 mgl/mL
- Volume: 380 ml
Total Time: 100 min
Exposure Time: 47 min
Exposure: 5344 mGy
Shooting date : 2018-10-08
Last update : 2019-06-18
Last update : 2019-06-18
OptiRAY® / Guerbet
Optiray® contrast agent is lower osmolar, lower viscosity and nonionic.
Promus PREMIER™ / Boston Scientific
Everolimus-Eluting Platinum Chromium Coronary Stent System
Workshop on Complex PCI (UHZ - Bad Krozingen)
We are pleased to announce you that the Guerbet Masterclass which took place on October 2018 at the UHZ (Bad Krozingen, Germany) is available online for all participants and incathlab members. ...
Share
Suggestions
Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Honolulu : Wednesday, July 5th 2023 from 06am to 07am (GMT-10)
San Francisco : Wednesday, July 5th 2023 from 09am to 10am (GMT-7)
New York : Wednesday, July 5th 2023 from 12pm to 01pm (GMT-4)
Buenos Aires : Wednesday, July 5th 2023 from 01pm to 02pm (GMT-3)
Reykjavik : Wednesday, July 5th 2023 from 04pm to 05pm (GMT)
London / Dublin : Wednesday, July 5th 2023 from 05pm to 06pm (GMT+1)
Paris / Berlin : Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Istanbul : Wednesday, July 5th 2023 from 07pm to 08pm (GMT+3)
Moscou / Dubaï : Wednesday, July 5th 2023 from 08pm to 09pm (GMT+4)
Bangkok : Wednesday, July 5th 2023 from 11pm to 12am (GMT+7)
Shanghai : Thursday, July 6th 2023 from 12am to 01am (GMT+8)
Tokyo : Thursday, July 6th 2023 from 01am to 02am (GMT+9)
Sydney : Thursday, July 6th 2023 from 03am to 04am (GMT+11)
Wellington : Thursday, July 6th 2023 from 05am to 06am (GMT+13)
San Francisco : Wednesday, July 5th 2023 from 09am to 10am (GMT-7)
New York : Wednesday, July 5th 2023 from 12pm to 01pm (GMT-4)
Buenos Aires : Wednesday, July 5th 2023 from 01pm to 02pm (GMT-3)
Reykjavik : Wednesday, July 5th 2023 from 04pm to 05pm (GMT)
London / Dublin : Wednesday, July 5th 2023 from 05pm to 06pm (GMT+1)
Paris / Berlin : Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Istanbul : Wednesday, July 5th 2023 from 07pm to 08pm (GMT+3)
Moscou / Dubaï : Wednesday, July 5th 2023 from 08pm to 09pm (GMT+4)
Bangkok : Wednesday, July 5th 2023 from 11pm to 12am (GMT+7)
Shanghai : Thursday, July 6th 2023 from 12am to 01am (GMT+8)
Tokyo : Thursday, July 6th 2023 from 01am to 02am (GMT+9)
Sydney : Thursday, July 6th 2023 from 03am to 04am (GMT+11)
Wellington : Thursday, July 6th 2023 from 05am to 06am (GMT+13)
Left Main and Bifurcation treatment:
impact of clinical trials in daily practice
Share
Antegrade IVUS-guided re-entry after failed AWE, ADR and retrograde approach
Dr Mashayekhi & Dr Azzalini
Share
Retrograde rescue RCA CTO after failed new antegrade fenestration technique
Dr Ferenc & Dr Carlino
Share
Heavily calcified RCA-CTO in low ejection fraction with retrograde epicardial approach
Dr Mashayekhi & Dr Ayoub
Share